Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metoprolol Optimal Dosing in Chinese ACS Patients
NCT03413410Unknown
- Start
- Feb 2018
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of metoprolol in acute coronary syndrome (ACS). Primary endpoint: Percentage of patients achieving target dose at 1 month. Status: unknown.
02
Drugs
metoprolol
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT03413410.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03413410.